These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37250145)

  • 1. Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B.
    Sang N; Zhong X; Gou K; Liu H; Xu J; Zhou Y; Zhou X; Liu Y; Chen Z; Zhou Y; Li Y; Tao L; Su N; Zhou L; Qiu J; Yang X; Zuo Z; Fu L; Zhang J; Li D; Li C; Sun Q; Lei J; Li R; Yang S; Cen X; Zhao Y
    MedComm (2020); 2023 Jun; 4(3):e269. PubMed ID: 37250145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy.
    Liu H; Wei J; Sang N; Zhong X; Zhou X; Yang X; Zhang J; Zuo Z; Zhou Y; Yang S; Du J; Zhao Y
    Med Oncol; 2021 Sep; 38(10):124. PubMed ID: 34491469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer.
    Peng W; Zhang H; Tan S; Li Y; Zhou Y; Wang L; Liu C; Li Q; Cen X; Yang S; Zhao Y
    Ther Adv Med Oncol; 2020; 12():1758835920937428. PubMed ID: 32754230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway.
    Li Y; Tao L; Zuo Z; Zhou Y; Qian X; Lin Y; Jie H; Liu C; Li Z; Zhang H; Zhang H; Cen X; Yang S; Zhao Y
    Cancer Lett; 2019 Jul; 454():179-190. PubMed ID: 30978443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine-Specific Histone Demethylase 1 Promotes Oncogenesis of the Esophageal Squamous Cell Carcinoma by Upregulating DUSP4.
    Han J; Ye S; Chen J; Wang K; Jin J; Zeng Z; Xue S
    Biochemistry (Mosc); 2021 Dec; 86(12):1624-1634. PubMed ID: 34937541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma
    Zhu L; Wang J; Kong W; Huang J; Dong B; Huang Y; Xue W; Zhang J
    Acta Pharm Sin B; 2019 Mar; 9(2):324-334. PubMed ID: 30972280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of the Histone Lysine-Specific Demethylase 1 Is Involved in Human Hepatocellular Carcinoma.
    Kim S; Bolatkan A; Kaneko S; Ikawa N; Asada K; Komatsu M; Hayami S; Ojima H; Abe N; Yamaue H; Hamamoto R
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31805626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients.
    Zhao ZK; Yu HF; Wang DR; Dong P; Chen L; Wu WG; Ding WJ; Liu YB
    World J Gastroenterol; 2012 Dec; 18(45):6651-6. PubMed ID: 23236241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5-LSD1-NF-κB oncogenic signaling.
    Hu B; Xu Y; Li YC; Huang JF; Cheng JW; Guo W; Yin Y; Gao Y; Wang PX; Wu SY; Zhou J; Fan J; Yang XR
    Clin Transl Med; 2020 Dec; 10(8):e233. PubMed ID: 33377659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of LSD1 enhances the cytotoxic and apoptotic effects of regorafenib in hepatocellular carcinoma cells.
    Wu LW; Zhou DM; Zhang ZY; Zhang JK; Zhu HJ; Lin NM; Zhang C
    Biochem Biophys Res Commun; 2019 May; 512(4):852-858. PubMed ID: 30929918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.
    Zou ZK; Huang YQ; Zou Y; Zheng XK; Ma XD
    Int J Mol Med; 2017 Aug; 40(2):319-328. PubMed ID: 28627608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties.
    Wang J; Lu F; Ren Q; Sun H; Xu Z; Lan R; Liu Y; Ward D; Quan J; Ye T; Zhang H
    Cancer Res; 2011 Dec; 71(23):7238-49. PubMed ID: 21975933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
    Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
    J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
    Li Y; Qian X; Lin Y; Tao L; Zuo Z; Zhang H; Yang S; Cen X; Zhao Y
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34498714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of LSD1 in hepatocellular carcinoma: a latent target for the diagnosis and therapy of hepatoma.
    Zhao ZK; Dong P; Gu J; Chen L; Zhuang M; Lu WJ; Wang DR; Liu YB
    Tumour Biol; 2013 Feb; 34(1):173-80. PubMed ID: 23015317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy.
    Schulte JH; Lim S; Schramm A; Friedrichs N; Koster J; Versteeg R; Ora I; Pajtler K; Klein-Hitpass L; Kuhfittig-Kulle S; Metzger E; Schüle R; Eggert A; Buettner R; Kirfel J
    Cancer Res; 2009 Mar; 69(5):2065-71. PubMed ID: 19223552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines.
    Murray-Stewart T; Woster PM; Casero RA
    Amino Acids; 2014 Mar; 46(3):585-94. PubMed ID: 23508577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
    He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
    Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coordination between ZNF217 and LSD1 contributes to hepatocellular carcinoma progress and is negatively regulated by miR-101.
    Si W; Zhao Y; Zhou J; Zhang Q; Zhang Y
    Exp Cell Res; 2019 Jun; 379(1):1-10. PubMed ID: 30898548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.